CA
NZ
UK
AU
IND
US
American Healthcare REIT, Inc. filed a current report on September 14, 2026, disclosing the release of an investor presentation intended for use in meetings with investors and other stakeholders.
abrdn Global Infrastructure Income Fund filed a Form 8-K with the SEC on September 11, 2026, disclosing that its Board of Trustees approved a transferable rights offering to holders of the Fund's common shares of beneficial interest.
Oracle Corporation filed an 8-K with the SEC on September 14, 2026, disclosing that Executive Chair and Chief Technology Officer Larry Ellison cancelled his 10b5-1 plan to sell Oracle stock, with no shares sold under the plan prior to its termination.
State Street Corporation filed a Form 8-K on September 14, 2026, disclosing two executive leadership appointments effective immediately: Mostapha Tahiri as President of State Street Alpha, and Ann Fogarty as Enterprise Chief Operating Officer.
Flowserve Corporation filed an 8-K with the SEC on September 14, 2026, disclosing the resignation of Chief Financial Officer Amy B. Schwetz and the appointment of Brian Ezzell as her successor, effective October 1, 2026.
Bally's Corporation filed a Form 8-K with the SEC on September 14, 2026, disclosing that its subsidiary Bally's New York Operating Company, LLC entered into a senior secured loan agreement on September 4, 2026, providing up to $560 million in term loan commitments to …
Immunocore Holdings plc filed a Form 8-K with the SEC on September 14, 2026, disclosing that its Phase 3 TEBE-AM clinical trial has achieved target patient enrollment.
NPK International Inc. filed an 8-K with the SEC on September 14, 2026, disclosing the appointment of James Barton as Executive Vice President, Commercial Growth & Operations, effective September 22, 2026.
Cullinan Therapeutics, Inc. filed a Form 8-K on September 14, 2026, reporting results from the Phase 3 REZILIENT3 clinical trial evaluating zipalertinib plus chemotherapy in first-line treatment of EGFR exon 20 insertion mutation-positive non-small cell lung cancer.
PBF Energy Inc. and PBF Holding Company LLC filed an 8-K on September 14, 2026, disclosing a planned private offering of $500.0 million in senior unsecured exchangeable notes due 2032 and a conditional notice of full redemption of existing 7.875% Senior Unsecured Notes due …
Please wait processing your request...